For decades, the miracle of childhood cancer survival has carried a quiet shadow: the very drugs that cure young patients may accelerate the biological aging of their healthy cells, compressing a lifetime of genetic wear into mere months of treatment. Researchers across four leading British institutions have now mapped, with unprecedented precision, the DNA damage platinum-based chemotherapy leaves behind in blood and liver tissue — offering the first coherent biological explanation for why so many survivors later face secondary cancers, liver disease, and premature aging. The discovery does n
Study reveals how childhood chemotherapy 'ages' healthy cells, explaining long-term survivor risks
Childhood cancer survivors face increased risk of secondary cancers, liver disease, and premature aging health conditions due to chemotherapy-induced DNA damage.